COVID-19 syndrome, which was previously found to severely affect children, has been shown to be more dangerous than thought, as young people may also experience the same symptoms. Compared with Kawasaki disease, the “child polysacle inflammatory syndrome” (MIS-C) after contracting the new coronavirus has similarities. British doctors warned back in late April that some children had suffered from strange inflammatory syndromes. In addition, hundreds of cases are registered in the United States alone, and MIS-C patients require professional care.
Doctors can’t explain why the syndrome has become so common, but some believe it has found signs of predictable serious cases.
While most children do recover from MIS-C, unfortunately many people still die after contracting the disease, and the syndrome appears to be affecting younger groups, meaning that care must be prepared for this possibility.
Jennifer Lighter, a pediatric infectious disease physician at NYU Langone, told The Washington Post that post-COVID-19 syndrome may be more dangerous for adolescents.
The cases of young patients are more similar to traditional Kawasaki disease, but the response of multiple organs in adolescents to the new coronavirus is more ‘overwhelming’ and can lead to a more serious condition.
Kawasaki disease expert Jane Burns added that doctors may be underdiagnosed with young people due to a variety of factors. The anatomy of older patients makes it more difficult for children to have heart ultrasounds than in groups of age.
The CDC has listed information about MIS-C on its website, such as symptoms that may be associated with fever, abdominal pain, vomiting, diarrhea, neck pain, rash, eye congestion, and tiredness. In view of this, such patients should contact their parents and doctor seeking assistance immediately.
If symptoms include breathing difficulties, chest pain or compression, cognitive dissonance, sleepiness, inability to stay awake, bruising of the lips, and severe diarrhea, you will need immediate emergency care.
James Schneider, an intensive care physician at Northwell Health Pediatrics, told The Washington Post that MIS-C patients cannot be treated at home.
Because it may require blood pressure regulation, steroids, anticoagulants, immunoglobulins and other drugs, and even need the assistance of a ventilator. Although some of the children received first aid as a result of cardiac arrest, all 44 patients diagnosed by the hospital survived.
In addition, Northwell Health Long Island Jewish Medical Center is treating a 25-year-old patient, several young patients in their 20s at NYU Langone Hospital, and a 20-year-old patient in San Diego.
Although classified as an adult group of 18 or older, this is only a one-size-fits-all definition of the law, contradicting the views of human biologists.
Doctors try to understand why adults are prone to the syndrome, such as whether it is genetically caused, as IS COVID-19.
Curiously, antibodies against the virus were detected in PATIENTs who were about to be treated, indicating that they had been treated with COVID-19 in the previous weeks.
In other words, MIS-C may be a “delayed immune response” to the original infection. To date, 20 states in the United States have reported hundreds of cases.
As of Thursday, New York City had contributed 147 of them, and at least three children had died, and a 15-year-old girl from Maryland had died, the Washington Post reported.